Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FLJ20729 Peptide

Reactivité: Humain Hôte: Synthetic BP, IHC, WB
N° du produit ABIN976912
  • Antigène
    FLJ20729
    Origine
    Humain
    Source
    Synthetic
    Application
    Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-FLJ20729 antibody (Catalog #: ARP34573_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    FLJ20729
    Sujet
    TRMT1 is a tRNA(m(2)(2)G(26))dimethyltransferase

    Alias Symbols: BCD1, C1orf181, NY-BR-75, FLJ20729

    Protein Interaction Partner: SMAD2

    Protein Size: 470
    Poids moléculaire
    54 kDa
    ID gène
    54680
    NCBI Accession
    NM_017953, NP_060423
    UniProt
    Q9NWN0
Vous êtes ici:
Support technique